The addition of CXCL13 to breast cancer cells in vitro increased expression of matrix metalloproteinase-9 (MMP-9) and genes reasonable for driving the epithelial to mesenchymal transition (EMT) (73). This evidence concerns the gene CXCL13 and breast cancer.